About this trial
Sepsis is defined as a life-threatening organ dysfunction that is caused by a dysregulated host response to infection. Severe sepsis is the most common cause of death among critically ill patients in non-coronary intensive care units (ICU). Sustained excessive inflammation and immune dysfunction have been confirmed to play a key role in organ damage and early death of sepsis patients. Therefore, it is important to reduce excessive inflammatory response mediated by immune cells and pro-inflammatory cytokines in the acute phase of sepsis.
Single-cell RNA sequencing performed on both septic patients and mice suggest that changes in Tcm (CD3+ CD8+ CD44+ CD127+ CD62L+) and Tem (CD3+ CD8+ CD44+ CD127+ CD62L -) in the acute phase of sepsis may play an important role in sepsis. In addition, animal researches showed that Tcm and Tem decreased decreased continuously at 24, 48 and 72h after cecal ligation and perforation (CLP) in mice, and the adoptive transfer of Tcm , sorting from spleen of mice 24h after CLP , but not Tem improved 7-day survival rate of sepsis mice.
This observational study is aimed to investigate the quantity and proliferation of Tcm and Tem in the acute phase of sepsis and their correlation with severity level and mortality of septic patients in ICU.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
patients with sepsis defined based on Sepsis 3.0 criteria
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Absolute number of CD8+T subsets in the peripheral blood (0 hour)
CD3+ CD8+ CCR7+ CD127high CD62L+ CD27high CD45RA- cells,and CD3+ CD8+ CCR7- CD127- CD62L- CD27low CD45RA- cells
Absolute number of CD8+T subsets in the peripheral blood (24 hours)
CD3+ CD8+ CCR7+ CD127high CD62L+ CD27high CD45RA- cells,and CD3+ CD8+ CCR7- CD127- CD62L- CD27low CD45RA- cells
Absolute number of CD8+T subsets in the peripheral blood (48 hours)
CD3+ CD8+ CCR7+ CD127high CD62L+ CD27high CD45RA- cells,and CD3+ CD8+ CCR7- CD127- CD62L- CD27low CD45RA- cells
Absolute number of CD8+T subsets in the peripheral blood (72 hours)
CD3+ CD8+ CCR7+ CD127high CD62L+ CD27high CD45RA- cells,and CD3+ CD8+ CCR7- CD127- CD62L- CD27low CD45RA- cells
Secondary outcomes
Mechanical ventilation time after inclusion
Patients requiring mechanical ventilation after study inclusion
Total hospital length of stay
Total length of hospital stay
In-hospital mortality
Mortality rates for the entire period of hospitalization
90-day readmission rate
Percentage of readmission to hospital within 90 days of study inclusion
Sponsors and contacts
Click on the lead sponsor to view all of their trials.